Discovery of KT-474a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
Article in Journal of Medicinal Chemistry (August 2024)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Article in Journal of Medicinal Chemistry (August 2024)
Article in Journal of Investigative Dermatology (July 2024)
Preprint in bioRxiv (July 2024)